Raffa Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-351
Closed -$1.29K – 1669
2026
Q2
$1.29K Buy
+351
New +$1.17K ﹤0.01% 942

Other funds holding RXRX

Raffa Wealth Management's RXRX Position: Q3 2026 in Review

Raffa Wealth Management sold out of Recursion Pharmaceuticals (RXRX) in Q3 2026, closing a stake of 351 shares — an estimated $1.29K sold.

Raffa Wealth Management first reported a position in RXRX in Q2 2026 and held it in 1 quarter. The position peaked at $1.29K in Q2 2026. 352 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.

  • Raffa Wealth Management reported no remaining Recursion Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Raffa Wealth Management sold 351 Recursion Pharmaceuticals shares in Q3 2026, an estimated $1.29K.
  • Raffa Wealth Management first reported a position in Recursion Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • Raffa Wealth Management's Recursion Pharmaceuticals position peaked at $1.29K in Q2 2026.
  • 352 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.

Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.